Brandon Capital

Brandon Capital is an investment firm.

Active

Updated: Feb 28, 2026 ·

About

Brandon Capital is Australasia's leading life science venture capital firm, with a strong global presence supported by key partnerships and team members. The firm focuses on investing in promising biomedical opportunities that have the potential to improve patient lives. Its investment scope includes companies operating in pharmaceuticals, biotechnology, and healthcare sectors.

As a funds management business, Brandon Capital aims to generate quality returns for Australia's leading superannuation funds by strategically deploying capital into innovative life science ventures.

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Feb 12, 2026	OncoRes Medical	$19.2M Venture Round	Brandon Capital	Morgans Financial Limited, Radar Ventures, The Table Club network

Financial History

Total Raised

N/A

Valuation

N/A

Deep Dive

Brandon Capital operates as a prominent life science venture capital firm, recognized for its leadership within Australasia and its established global footprint. The firm's investment strategy centers on identifying and supporting biomedical opportunities that hold significant potential for advancing patient care and outcomes. This includes a broad range of companies across pharmaceuticals, biotechnology, and the wider healthcare industry.

The firm functions as a funds management entity, with a core objective of delivering strong returns to Australia's leading superannuation funds. This is achieved through targeted investments in the life sciences sector, fostering innovation and growth within the industry.

Brandon Capital has been selected by the Australian Government to play a pivotal role in building a significant life sciences fund through the Medical Research Commercialisation Fund (MRCF). This initiative underscores the firm's importance in the national life science ecosystem and its capacity to manage substantial capital for strategic development.

Recently, Brandon Capital successfully raised its sixth fund, securing $290 million. This represents the firm's largest fund to date and has already facilitated investments in companies such as radiopharma AdvanCell, ADC-focused Myricx Bio, and German oncology outfit CatalYm, demonstrating its active investment approach across diverse life science sub-sectors.

Sources

Frequently Asked Questions

What types of companies does Brandon Capital typically invest in?

Brandon Capital invests in companies operating in pharmaceuticals, biotechnology, and healthcare, specifically targeting promising biomedical opportunities that can improve patient lives.

Has Brandon Capital recently closed a new fund?

Yes, Brandon Capital recently raised its sixth fund, securing $290 million, which is its largest fund to date and has already made several notable investments.